MarketInOut Stock Screener Log In | Sign Up

Seegene Inc

KRX • Healthcare • Biotechnology • Quote as of 10/30/2026
Seegene Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeKRX
Market Capitalization1,526,404 mln
Float21.40 mln
Earnings Date11/06/2026

EPS

1,748
Exceptional

P / E

19.02
Moderately valued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.65
Likely reliable

1-Year Forecast

48,000
Exceptional upside

Relative Strength

18 / 100
Significantly lagging

Business Description

Founded in 2000 and based in Seoul, South Korea, Seegene develops and sells medical testing products that help identify a wide range of infectious diseases and genetic markers. Its tests cover conditions such as respiratory and gastrointestinal infections, sexually transmitted diseases, tuberculosis, sepsis, and meningitis, among others. The company works with Werfen to jointly develop advanced diagnostic testing solutions for the global market.

Key Fundamentals

EPS1,748
P/E19.02
ROE7.80
RPS11,091
ROIC7.66
ROA6.39
Interest Cover16.46
EBITDA, mln177,590
EV / EBITDA5.03
EV / EBIT8.09
Revenue, mln509,273
EV / Revenue1.75

Quote Details

Last 33,250
Change -350 (-1.04%)
Open 33,600
Volume 177,570
Turnover 5,904,202,752
Average Volume 311,885

Financial Ratios

Pre-Tax Profit Margin21
Current Ratio4.62
Price / Book1.47
Price / Tangible Book1.51
Price / Free Cash Flow15.44
Debt / Equity0.13
Price / Sales3.02

Financial Strength

Altman Z-Score6.09
Piotroski F-Score 8 / 9
Beneish M-Score-2.65
Price to Intrinsic Value0.65
Price to Graham Number1.09
1-Year Target Price48,000
Shiller PE Ratio10.70

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.77% 51 / 100   
1 Month -1.34% 77 / 100   
2 Months 22.24% 92 / 100   
6 Months 36.06% 98 / 100   
1 Year 35.09% 87 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog